Metabolic phenotype prediction from genotyping data: a bottleneck for the implementation of pharmacogenetics in drug development and clinical practice-Reference-Cited by-同舟云学术

Metabolic phenotype prediction from genotyping data: a bottleneck for the implementation of pharmacogenetics in drug development and clinical practice

Published:2015-01-01 Issue:3 Volume:30 Page:
ISSN:2363-8915
Container-title:Drug Metabolism and Personalized Therapy
language:
Short-container-title:

Author:

LLerena Adrián,Peñas-Lledó Eva M.

Publisher

Walter de Gruyter GmbH

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics

Link

https://www.degruyter.com/document/doi/10.1515/dmpt-2015-0025/pdf

Reference22 articles.

1. PRAC recommends restrictions on the use of codeine for cough and cold in children Available at http www ema europa eu docs en GB document library Press release WC pdf accessed;July

2. de la Relationship between risperidone hydroxy - risperidone plasma concentrations and enzyme activity in psychiatric patients;Berecz;Pharmacopsychiatry,2002

3. de la Use of the mesoridazine / thioridazine ratio as a marker for enzyme activity;Llerena;Ther Drug Monit,2000

4. de la Effect of thioridazine dosage on the debrisoquine hydroxylation phenotype in psychiatric patients with different genotypes;LLerena;Ther Drug Monit,2001

5. EM genotype and debrisoquine hydroxylation phenotype in;LLerena;Pharmacogenomics J,2012

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacogenetics: ethnicity, treatment and health in Latin American populations;Pharmacogenomics;2023-06

2. Clinical implementation of pharmacogenetics and personalized drug prescription based on e-health: the MedeA initiative;Drug Metabolism and Personalized Therapy;2020-09-02

3. Clinical implementation of pharmacogenetics and personalized drug prescription based on e-health: the MedeA initiative;Drug Metabolism and Drug Interactions;2020-09-01

4. Challenges and Opportunities for Clinical Pharmacogenetic Research Studies in Resource-limited Settings: Conclusions From the Council for International Organizations of Medical Sciences–Ibero-American Network of Pharmacogenetics and Pharmacogenomics Meeting;Clinical Therapeutics;2020-08

5. Interethnic Variability in CYP2D6, CYP2C9, and CYP2C19 Genes and Predicted Drug Metabolism Phenotypes Among 6060 Ibero- and Native Americans: RIBEF-CEIBA Consortium Report on Population Pharmacogenomics;OMICS: A Journal of Integrative Biology;2018-09